Microporous Drug Delivery System for Sustained Anti-VEGF Delivery to the Eye

PURPOSE: To describe a novel microporous drug delivery system (DDS) for sustained anti- vascular endothelial growth factor (VEGF) delivery to the eye and to evaluate its efficacy in a corneal injury model. METHODS: A macro-porous DDS (1.5 × 1.5 × 4 mm) loaded with 2 mg of bevacizumab was implanted s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Chengxin, Singh, Arushi, Qian, Grace, Wolkow, Natalie, Dohlman, Claes H., Vavvas, Demetrios G., Chodosh, James, Paschalis, Eleftherios I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422759/
https://www.ncbi.nlm.nih.gov/pubmed/32855852
http://dx.doi.org/10.1167/tvst.9.8.5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422759/
https://www.ncbi.nlm.nih.gov/pubmed/32855852
http://dx.doi.org/10.1167/tvst.9.8.5

Ejemplares similares